Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 3,686	$ 4,030
Receivable from the sale of IQOS System commercialization rights	0	1,721
Other	71	48
Inventories:
Leaf tobacco	649	704
Other raw materials	204	186
Work in process	22	24
Finished product	340	266
Inventory, net	1,215	1,180
Income taxes	496	103
Other current assets	117	138
Total current assets	5,585	7,220
Property, plant and equipment, at cost:
Land and land improvements	123	123
Buildings and building equipment	1,535	1,478
Machinery and equipment	2,684	2,578
Construction in progress	240	248
Property, plant and equipment, at cost	4,582	4,427
Less accumulated depreciation	2,930	2,819
Property, plant and equipment, net	1,652	1,608
Goodwill	6,791	5,177
Other intangible assets, net	13,686	12,384
Investments in equity securities ($0 million and $250 million at December 31, 2023 and 2022, respectively, measured at fair value)	10,011	9,600
Other assets	845	965
Total Assets	38,570	36,954
Liabilities
Current portion of long-term debt	1,121	1,556
Accounts payable	582	552
Accrued liabilities:
Marketing	716	599
Settlement charges	2,563	2,925
Other	1,902	1,299
Deferred gain from the sale of IQOS System commercialization rights	2,700	0
Dividends payable	1,735	1,685
Total current liabilities	11,319	8,616
Long-term debt	25,112	25,124
Deferred income taxes	2,799	2,897
Accrued pension costs	130	133
Accrued postretirement health care costs	1,079	1,083
Deferred gain from the sale of IQOS System commercialization rights	0	2,700
Other liabilities	1,621	324
Total liabilities	42,060	40,877
Contingencies (Note 17)
Stockholders’ Equity (Deficit)
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued)	935	935
Additional paid-in capital	5,906	5,887
Earnings reinvested in the business	31,094	29,792
Accumulated other comprehensive losses	(2,673)	(2,771)
Cost of repurchased stock (1,042,499,542 shares at December 31, 2023 and 1,020,427,195 shares at December 31, 2022)	(38,802)	(37,816)
Total stockholders’ equity (deficit) attributable to Altria	(3,540)	(3,973)
Noncontrolling interests	50	50
Total stockholders’ equity (deficit)	(3,490)	(3,923)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 38,570	$ 36,954